NEW YORK--(BUSINESS WIRE)--OverT Bio, a data-driven company working to unlock the curative potential of cell therapies in solid tumors, announced today that it has raised $16 million in seed funding.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback